Indian Army Pharmaceutical Procurement: Essential Medications and Medical Supplies Supply

The Department of Military Affairs, under the Ministry of Defence and for the esteemed Indian Army, hereby invites bids for the procurement of a comprehensive range of pharmaceutical products. This tender, identified by Bid Number GEM/2026/B/8213959, is open for submissions from 10:56 AM on 29-10-2026 until 11:00 AM on 09-11-2026. The scope of this requirement encompasses a significant total quantity of 28,390 units of various medications and medical supplies. Key items include Fluoxetine HCI 20 mg Capsules, Lorazepam 1 mg Tablets, Mirtazapine 15 mg Tablets, Clozapine 25 mg Tablets, Desvenlafaxine 50 mg Tablets, Risperidone 2 mg Tablets, Aripiprazole 10 mg Tablets, Quetiapine 50 mg Tablets, Amisulpride 200 mg Tablets, Quetiapine 25 mg Tablets, Etophylline 115mg and Theophylline 35 mg in slow-release form Tablets, LevoSalbutamol Sulphate 2.5 ml containing 1.25 mg Respules, Sterile water for ampoules of 10 ml, Linezolid 600 mg Tablets, Mirabegron 25 mg Capsules, Silodosin 4 mg Tablets, Antiphlebitis cream in 15g/20g tubes, Sildenafil Citrate 50 mg Tablets, and Tolterodine Tartrate 2 mg Tablets. This procurement is critical for ensuring the continued health and well-being of personnel under the purview of the Indian Army, and all interested and qualified suppliers are encouraged to participate.